Deferiprone is an iron chelating agent and pyridone derivative used in the clinical management of iron overload, specifically in patients with hereditary hemoglobinopathies such as thalassemia who require… Read more












Deferiprone is an iron chelating agent and pyridone derivative used in the clinical management of iron overload, specifically in patients with hereditary hemoglobinopathies such as thalassemia who require chronic blood transfusions. To ensure the safety and efficacy of this treatment, pharmaceutical laboratories rely on high-quality reference materials for rigorous analytical testing and quality control. This category provides access to essential reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and key metabolites like the 3-O-glucuronide. Furthermore, researchers use these materials alongside stable isotope-labelled compounds to facilitate accurate impurity profiling and to support the method validation of pharmaceutical formulations. These analytical tools allow for the precise identification and quantification of substances throughout the drug development and manufacturing lifecycle.